BCR-ABL1 transcript decline ratio combined BCR-ABL1IS as a precise predictor for imatinib response and outcome in the patients with chronic myeloid leukemia
暂无分享,去创建一个
Z. Ge | Chunhua Song | Lidong Zhao | M. McGrath | J. Zi | Huihui Song | Z. Cai | Xiting Jia | Shujun Wang